Banzel 400 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FEHQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $118,474
Award facts
- Contract value 100% obligated
- $118,473.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $118,473.78 to AmerisourceBergen Drug Corp for the supply of Banzel 400 mg tablets (120-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare systems. Banzel (rufinamide) is a specialty antiepileptic medication used in neurological treatment protocols, consistent with AmerisourceBergen's established portfolio of brand-name and generic pharmaceuticals supplied to the Defense Health Agency and other federal healthcare systems. The non-set-aside designation reflects the competitive nature of AmerisourceBergen's qualification as a prime vendor capable of fulfilling federal medical supply requirements through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FEHQW?
SPE2DB25FEHQW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FEHQW worth?
The government has obligated $118,474 on SPE2DB25FEHQW.
Is contract SPE2DB25FEHQW an order under another contract?
Yes. SPE2DB25FEHQW is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHQW competed?
The extent of competition for SPE2DB25FEHQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award